Hong Yuan Holding Group (HGYN)

Industrials · OQB

$0.040.00% today

Price as at 30 Sept 2026, 19:09 UTC. Quotes are delayed.

Fundamentals

Market cap$2.43M
Revenue growth (YoY)-76.3%
Profit margin3.5%
52-week range$0.00 to $0.24

Valuation and ratings

Moat score32/100
Overall rating28/100, very low quality

Hong Yuan Holding Group trades at $0.04. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.

Our moat model scores it 32 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

About Hong Yuan Holding Group

Hong Yuan Holding Group does not have significant operations. previously, the company was engaged in the development and commercialization of bio-based resins. The company was formerly known as Cereplast, Inc. and changed its name to Hong Yuan Holding Group in June 2021. Hong Yuan Holding Group was incorporated in 2001 and is based in Zhengzhou, China.

Industry: Integrated Freight & LogisticsEmployees: 10HQ: China

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

HGYN passes 1 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

HGYN peers

The largest companies in the same industry (Integrated Freight & Logistics), then in the same sector.

Every industrials company we cover is on the Industrials hub.

Common questions

Where does SteadyShares get its HGYN data?

Fundamentals for HGYN come from company filings and exchange data, as listed on OQB; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 19:09 UTC and is delayed. Our data quality score for this company is 63/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for HGYN, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.